We are analyzing https://link.springer.com/article/10.1007/s11926-012-0304-0.

Title:
Involvement of PDGF in Fibrosis and Scleroderma: Recent Insights from Animal Models and Potential Therapeutic Opportunities | Current Rheumatology Reports
Description:
Fibrosis is the principal characteristic of the autoimmune disease known as scleroderma or systemic sclerosis (SSc). Studies published within the last three years suggest central involvement of platelet-derived growth factors (PDGFs) in SSc-associated fibrosis. PDGFs may also be involved in SSc-associated autoimmunity and vasculopathy. The PDGF signaling pathway is well understood and PDGF receptors are expressed on collagen-secreting fibroblasts and on mesenchymal stem and/or progenitor cells that may affect SSc in profound and unexpected ways. Although much work remains before we fully understand how PDGFs are involved in SSc, there is much interest in using PDGF inhibitors as a therapeutic approach to SSc.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Careers

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

article, google, scholar, cas, pubmed, cells, fibrosis, systemic, growth, sclerosis, cell, development, pdgf, scleroderma, rheum, arthritis, factor, plateletderived, signaling, muscle, fibroblasts, mesenchymal, patients, receptor, content, olson, access, smooth, soriano, mice, imatinib, privacy, cookies, research, animal, models, disease, factors, nat, med, res, usa, expression, mouse, lymphatic, mural, induces, information, publish, search,

Topics {✒️}

neutralizing antibody specific fibroblast growth-promoting activity month download article/chapter platelet-derived growth factor platelet-derived growth factor open-label pilot trial open-label clinical trial platelet-derived growth factors platelet-dependent serum factor induces liver fibrosis pressure-overloaded mouse hearts epicardial-derived cell epithelial b-cell depletion therapy pdgf-a-mediated fibrosis mesenchymal stem heart-specific transgenic mice pdgf-b-deficient mice smooth muscle cells fibrotic diseases full article pdf mesenchyme-derived cells potential therapeutic opportunities autoimmune disease hyperresponsive pdgfrα signaling cancer research program mesenchymal progenitors distinct follicular dendritic cells connective tissue synthesis connective tissue remodeling privacy choices/manage cookies atrial fibrosis induced animal models cardiac mast cells induces cardiac fibrosis mouse model isolated pdgfrβ+ cells collagen-overproducing cells acute tissue injury satellite cells contribute perivascular cells identify pdgf alpha receptor imatinib prevents fibrosis drives systemic fibrosis distinct signaling pathways lack mural cells related subjects pericyte loss autoinflammatory gene signature multiorgan fibrosis observed progenitor cells

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Involvement of PDGF in Fibrosis and Scleroderma: Recent Insights from Animal Models and Potential Therapeutic Opportunities
         description:Fibrosis is the principal characteristic of the autoimmune disease known as scleroderma or systemic sclerosis (SSc). Studies published within the last three years suggest central involvement of platelet-derived growth factors (PDGFs) in SSc-associated fibrosis. PDGFs may also be involved in SSc-associated autoimmunity and vasculopathy. The PDGF signaling pathway is well understood and PDGF receptors are expressed on collagen-secreting fibroblasts and on mesenchymal stem and/or progenitor cells that may affect SSc in profound and unexpected ways. Although much work remains before we fully understand how PDGFs are involved in SSc, there is much interest in using PDGF inhibitors as a therapeutic approach to SSc.
         datePublished:2013-01-11T00:00:00Z
         dateModified:2013-01-11T00:00:00Z
         pageStart:1
         pageEnd:6
         sameAs:https://doi.org/10.1007/s11926-012-0304-0
         keywords:
            PDGF
            Scleroderma
            Fibrosis
            Mouse model
            Animal models
            Pericyte
            Imatinib
            Neutralizing antibody
            Therapeutic
            Rheumatology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11926-012-0304-0/MediaObjects/11926_2012_304_Fig1_HTML.gif
         isPartOf:
            name:Current Rheumatology Reports
            issn:
               1534-6307
               1523-3774
            volumeNumber:15
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Current Science Inc.
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Tomoaki Iwayama
               affiliation:
                     name:Oklahoma Medical Research Foundation
                     address:
                        name:Immunobiology and Cancer Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lorin E. Olson
               affiliation:
                     name:Oklahoma Medical Research Foundation
                     address:
                        name:Immunobiology and Cancer Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Involvement of PDGF in Fibrosis and Scleroderma: Recent Insights from Animal Models and Potential Therapeutic Opportunities
      description:Fibrosis is the principal characteristic of the autoimmune disease known as scleroderma or systemic sclerosis (SSc). Studies published within the last three years suggest central involvement of platelet-derived growth factors (PDGFs) in SSc-associated fibrosis. PDGFs may also be involved in SSc-associated autoimmunity and vasculopathy. The PDGF signaling pathway is well understood and PDGF receptors are expressed on collagen-secreting fibroblasts and on mesenchymal stem and/or progenitor cells that may affect SSc in profound and unexpected ways. Although much work remains before we fully understand how PDGFs are involved in SSc, there is much interest in using PDGF inhibitors as a therapeutic approach to SSc.
      datePublished:2013-01-11T00:00:00Z
      dateModified:2013-01-11T00:00:00Z
      pageStart:1
      pageEnd:6
      sameAs:https://doi.org/10.1007/s11926-012-0304-0
      keywords:
         PDGF
         Scleroderma
         Fibrosis
         Mouse model
         Animal models
         Pericyte
         Imatinib
         Neutralizing antibody
         Therapeutic
         Rheumatology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11926-012-0304-0/MediaObjects/11926_2012_304_Fig1_HTML.gif
      isPartOf:
         name:Current Rheumatology Reports
         issn:
            1534-6307
            1523-3774
         volumeNumber:15
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Current Science Inc.
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Tomoaki Iwayama
            affiliation:
                  name:Oklahoma Medical Research Foundation
                  address:
                     name:Immunobiology and Cancer Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lorin E. Olson
            affiliation:
                  name:Oklahoma Medical Research Foundation
                  address:
                     name:Immunobiology and Cancer Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Current Rheumatology Reports
      issn:
         1534-6307
         1523-3774
      volumeNumber:15
Organization:
      name:Current Science Inc.
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Oklahoma Medical Research Foundation
      address:
         name:Immunobiology and Cancer Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA
         type:PostalAddress
      name:Oklahoma Medical Research Foundation
      address:
         name:Immunobiology and Cancer Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Tomoaki Iwayama
      affiliation:
            name:Oklahoma Medical Research Foundation
            address:
               name:Immunobiology and Cancer Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA
               type:PostalAddress
            type:Organization
      name:Lorin E. Olson
      affiliation:
            name:Oklahoma Medical Research Foundation
            address:
               name:Immunobiology and Cancer Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Immunobiology and Cancer Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA
      name:Immunobiology and Cancer Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(188)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

6.13s.

LINK . SPRINGER . COM {}